Helen Toledano

Tel Aviv, TA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

CO2 Laser Matrixectomy for Refractory MEK Inhibitor-Induced Paronychia in Children: A Case Series.

CO2 Laser Matrixectomy for Refractory MEK Inhibitor-Induced Paronychia in Children: A Case Series.

Journal: Pediatric blood & cancer

Published: April 15, 2026

High-dose chemotherapy and craniospinal irradiation-sparing approach for WNT medulloblastoma of early childhood.

High-dose chemotherapy and craniospinal irradiation-sparing approach for WNT medulloblastoma of early childhood.

Journal: Journal of neuro-oncology

Published: December 10, 2025

Rapid Response to Trametinib Combined With Chemotherapy for Infant BRAF-Fused Chiasmatic Glioma.

Rapid Response to Trametinib Combined With Chemotherapy for Infant BRAF-Fused Chiasmatic Glioma.

Journal: Pediatric blood & cancer

Published: November 30, 2025

Incidence of Bevacizumab-Associated Toxicity in Children With Low-Grade Glioma With and Without Neurofibromatosis Type 1.

Incidence of Bevacizumab-Associated Toxicity in Children With Low-Grade Glioma With and Without Neurofibromatosis Type 1.

Journal: Pediatric blood & cancer

Published: September 23, 2025

Integrated clinical and molecular landscape of disseminated pediatric low-grade glioma.

Integrated clinical and molecular landscape of disseminated pediatric low-grade glioma.

Journal: Neuro-oncology

Published: June 11, 2025

Disseminated pediatric low-grade glioma and hydrocephalus: a multinational consortium analysis of incidence and mortality.

Disseminated pediatric low-grade glioma and hydrocephalus: a multinational consortium analysis of incidence and mortality.

Journal: Journal of neurosurgery. Pediatrics

Published: April 25, 2025

Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.

Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.

Journal: Nature medicine

Published: April 16, 2025

Brain tumor classification from FFPE samples using nanopore methylation sequencing.

Brain tumor classification from FFPE samples using nanopore methylation sequencing.

Journal: NAR cancer

Published: March 19, 2025

Excellent Outcome of Residual Pulmonary Metastases in Initially High Burden Metastatic Hepatoblastoma: A Case Series.

Excellent Outcome of Residual Pulmonary Metastases in Initially High Burden Metastatic Hepatoblastoma: A Case Series.

Journal: Journal of pediatric hematology/oncology

Published: February 24, 2025

Ocular Safety and Visual Acuity Stability in Pediatric Patients With Optic Pathway Gliomas and Orbital Plexiform Neurofibromas Treated With BRAF and MEK Inhibitors.

Ocular Safety and Visual Acuity Stability in Pediatric Patients With Optic Pathway Gliomas and Orbital Plexiform Neurofibromas Treated With BRAF and MEK Inhibitors.

Journal: Pediatric blood & cancer

Published: February 10, 2025

Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.

Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.

Journal: Nature medicine

Published: March 12, 2024

A Need for a Novel Survival Risk Scoring System for Intensive Care Admissions Due to Sepsis in Pediatric Hematology/Oncology Patients.

A Need for a Novel Survival Risk Scoring System for Intensive Care Admissions Due to Sepsis in Pediatric Hematology/Oncology Patients.

Journal: Journal of intensive care medicine

Published: November 20, 2023

Showing 1-12 of 68

Last Updated: 09/26/2026